HK1006365A1 - Hcg liquid formulations - Google Patents

Hcg liquid formulations

Info

Publication number
HK1006365A1
HK1006365A1 HK98105724A HK98105724A HK1006365A1 HK 1006365 A1 HK1006365 A1 HK 1006365A1 HK 98105724 A HK98105724 A HK 98105724A HK 98105724 A HK98105724 A HK 98105724A HK 1006365 A1 HK1006365 A1 HK 1006365A1
Authority
HK
Hong Kong
Prior art keywords
hcg
soln
liquid formulations
polyalcohol
mannitol
Prior art date
Application number
HK98105724A
Other languages
English (en)
Inventor
Fabrizio Samaritani
Patrizia Natale
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of HK1006365A1 publication Critical patent/HK1006365A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Semiconductor Memories (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Cosmetics (AREA)
HK98105724A 1995-03-21 1998-06-19 Hcg liquid formulations HK1006365A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1995/001055 WO1996029095A1 (en) 1995-03-21 1995-03-21 Hcg liquid formulations

Publications (1)

Publication Number Publication Date
HK1006365A1 true HK1006365A1 (en) 1999-02-26

Family

ID=8165977

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105724A HK1006365A1 (en) 1995-03-21 1998-06-19 Hcg liquid formulations

Country Status (16)

Country Link
US (1) US6706681B1 (de)
EP (1) EP0814841B1 (de)
JP (1) JP4165718B2 (de)
KR (1) KR100377967B1 (de)
AT (1) ATE209930T1 (de)
AU (1) AU707796B2 (de)
BR (1) BR9510567A (de)
DE (1) DE69524456T2 (de)
DK (1) DK0814841T3 (de)
ES (1) ES2166841T3 (de)
FI (1) FI117160B (de)
HK (1) HK1006365A1 (de)
NO (1) NO318997B1 (de)
PT (1) PT814841E (de)
UA (1) UA61053C2 (de)
WO (1) WO1996029095A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
EA001579B1 (ru) * 1997-01-30 2001-06-25 Хехст Марион Рассел Лтд. Лиофилизированная композиция морфогенетического фактора роста кости мр52 человека и способ её получения
SK287146B6 (sk) 2000-02-22 2010-01-07 Laboratoires Serono Sa Spôsob prípravy rekombinantného choriogonadotropínu - hCG zo vzorky
WO2002011753A1 (fr) * 2000-08-04 2002-02-14 Chugai Seiyaku Kabushiki Kaisha Preparations proteiniques a injecter
FR2869979B1 (fr) * 2004-05-06 2006-08-04 Packinox Sa Echangeur thermique a plaques
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
KR20080106636A (ko) * 2007-06-04 2008-12-09 동아제약주식회사 사람 융모성 성선자극호르몬 함유 즉시 사용형 주사 용액
DK2219607T3 (da) * 2007-11-01 2013-06-17 Merck Serono Sa Flydende LH-formuleringer
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
WO2011108010A2 (en) * 2010-03-05 2011-09-09 Intas Biopharmaceuticals Limited A thermostable liquid formulation of gonadotropins
EP2417982A1 (de) 2010-07-30 2012-02-15 Ferring B.V. Stabilisierung von Gonadotropinen
US20120265129A1 (en) 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
BR112015008753A2 (pt) 2012-10-18 2017-07-04 Neuralight Hd Llc tratamento de depressão e ptsd

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88233A (en) * 1987-11-03 1993-08-18 Genentech Inc Gamma interferon formulation
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations
US5385230A (en) * 1991-01-11 1995-01-31 Minnesota Mining And Manufacturing Company Adjustable tray assembly for use in desk drawers
JP2966592B2 (ja) * 1991-07-20 1999-10-25 萩原 義秀 安定化されたヒトモノクローナル抗体製剤
IT1250075B (it) * 1991-12-18 1995-03-30 Serono Cesare Ist Ricerca Composizioni farmaceutiche contenenti gonadotropine.

Also Published As

Publication number Publication date
NO318997B1 (no) 2005-05-30
UA61053C2 (en) 2003-11-17
JP4165718B2 (ja) 2008-10-15
ES2166841T3 (es) 2002-05-01
PT814841E (pt) 2002-03-28
KR19980702859A (ko) 1998-08-05
AU2110695A (en) 1996-10-08
DK0814841T3 (da) 2002-03-04
EP0814841A2 (de) 1998-01-07
FI117160B (fi) 2006-07-14
DE69524456T2 (de) 2002-08-01
US6706681B1 (en) 2004-03-16
EP0814841B1 (de) 2001-12-05
JPH11502205A (ja) 1999-02-23
NO974309D0 (no) 1997-09-18
AU707796B2 (en) 1999-07-22
BR9510567A (pt) 1998-06-23
DE69524456D1 (de) 2002-01-17
NO974309L (no) 1997-10-14
KR100377967B1 (ko) 2003-06-12
WO1996029095A1 (en) 1996-09-26
FI973745A0 (fi) 1997-09-22
FI973745A (fi) 1997-11-11
ATE209930T1 (de) 2001-12-15

Similar Documents

Publication Publication Date Title
HK1006365A1 (en) Hcg liquid formulations
CA2234140A1 (fr) Formulation pharmaceutique lyophilisee stable
EP0803796A3 (de) Anzeigesteuerungssystem mit Treibersignalverriegelung für eine nicht aktivierte optionale CRT-Anzeige
ITMI930578A0 (it) Metodo e dispositivo per salvare un'immagine di sitema su una memoria permanate, in modo indipendente dal sistema operativo
ES2190087T3 (es) Formulacion estabilizada de un anticuerpo.
ZA9610535B (en) Antagonists of gonadotropin releasing hormone.
ZA9610536B (en) Antagonists of gonadotropin releasing hormone.
AU8490091A (en) Construction and process for producing the same, associated construction elements and sets of construction elements
FR2690147B1 (fr) Plate-forme, notamment pour cabine d'ascenseur et monte-charge, en materiau composite.
IL122981A (en) R-n-¬1- ¬2-¬1-¬ 4-5- (2,3-dihydro ¬1,4¾ benzodioxinyl) piperazinyl¾ propyl¾-n- (2-pyridyl)- cyclohexane carboxamide methods for its preparation and pharmaceutical compositions containing it
WO2000072820A3 (en) Injectable anesthetic formulation
CA2386817A1 (en) The use of baclofen in the treatment of alcoholism
AU4480993A (en) Polydimethylsiloxanes for modulus reduction and method for their preparation
AU6569196A (en) An adjuvanted vaccine which is substantially free of non-host albumin
PL321736A1 (en) Bar joint
EP0599200A3 (de) Festkörperbildaufnahmevorrichtung und Verfahren zu ihrem Betrieb.
AU4964197A (en) Recombinant single-stranded equine chorionic gonadotropin
WO1997026867A3 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
Hunter Modern and ancient coral associations of the Cayman Islands
Pleydell Aspects of diagenesis and ichnology in the Olioocene-Miocene Bluff Formation of Grand Cayman Island, British West Indies
AU2001258638A1 (en) Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
MX9707121A (es) Formulaciones liquidas de gch.
IT8919481A0 (it) Sistema di articolazione per mobili e suo procedimento di montaggio.
FR2700019B3 (fr) Procédé et dispositif de contrôle d'injections dans le sol.
Motrya et al. Physical-chemical investigation of the systems HgS-SnS, HgS-SnS sub 2

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)
PF Patent in force
PE Patent expired

Effective date: 20150320